Fig. 2From: Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: the first reportT2-weighted magnetic resonance imaging of the spinal cord showed longitudinally extensive intramedullary high-intensity areas (between C5/6 and Th12/L1)Back to article page